BioNexus Gene Lab BGLC
-
-
-
已收盤：-
淨值比明細
年季 | 收盤價 | 權益總計(百萬) | 稅後權益報酬率(%) | 稅後純益(百萬) | 稅後資產報酬率(%) | 資產總計(百萬) |
|---|---|---|---|---|---|---|
| 2026Q1 | 2.14 | 8 | -6.51 | -1 | -5.95 | 9 |
| 2025Q4 | 3.95 | 9 | -13.66 | -1 | -12.49 | 9 |
| 2025Q3 | 5.47 | 7 | -9.3 | -1 | -7.83 | 8 |
| 2025Q2 | 3.07 | 8 | -8.41 | -1 | -6.8 | 9 |
| 2025Q1 | 2.36 | 8 | -8.54 | -1 | -6.9 | 9 |
| 2024Q4 | 2.8 | 8 | -3.83 | 0 | -3.16 | 10 |
| 2024Q3 | 4.45 | 9 | -15.14 | -1 | -12.95 | 11 |
| 2024Q2 | 4.75 | 10 | 1.61 | 0 | 1.36 | 11 |
| 2024Q1 | 7.06 | 9 | -1.09 | 0 | -0.92 | 11 |
| 2023Q4 | 5.3 | 10 | 3.18 | 0 | 2.69 | 11 |
| 2023Q3 | 8.7 | 10 | -33.34 | -3 | -26.95 | 11 |
| 2023Q2 | 6 | -4.14 | 0 | -3.22 | 8 | |
| 2023Q1 | 7 | -1.04 | 0 | -0.82 | 8 | |
| 2022Q4 | 7 | -2.4 | 0 | -1.9 | 9 | |
| 2022Q3 | 6 | -1.16 | 0 | -0.95 | 8 | |
| 2022Q2 | 7 | 0 | 8 |